Massacusetts General Hospital

Boston, Massachusetts 02114

0 studies enrolling now · 10 studies all time

What they study most

Breast Cancer, Diet Habit, Fallopian Tube Cancer, Food Preferences, Low-grade Glioma, Metabolic Syndrome, Nutritional and Metabolic Disease, Obesity, Ovarian Cancer, Primary Peritoneal Carcinoma, Small Cell Lung Cancer, Smoking Cessation

Studies at this site

• DAY101 In Gliomas and Other Tumors — Completed
• PREMIER: PREvention of Metabolic Illness Through prEcision nutRition — Completed
• Designing an Implementation Strategy for Lung Screening and Smoking Cessation Treatment in Community Health Centers — Completed
• Study of Ibrutinib in Patients With Symptomatic, Previously Untreated Waldenstrom's Macroglobulinemia, and Impact on Tumor Genomic Evolution Using Whole Genome Sequencing — Completed
• An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer. — Completed
• Engagement With an Adaptive Mobile Health Smoking Cessation Intervention — Completed
• A Text Messaging Program for Smokers in Primary Care — Completed
• A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer — Stopped early
• Study of Hsp90 Inhibitor, STA-9090 for Relapsed or Refractory Small Cell Lung Cancer — Completed
• Dose Dense Abraxane in Adjuvant Chemotherapy for Breast Cancer — Completed